Clinically relevant in vitro biofilm models: A need to mimic and recapitulate the host environment

Bjarnsholt, 2008, Why chronic wounds will not heal: a novel hypothesis, Wound Repair Regen, 16, 2, 10.1111/j.1524-475X.2007.00283.x Coenye, 2010, In vitro and in vivo model systems to study microbial biofilm formation, J Microbiol Methods, 83, 89, 10.1016/j.mimet.2010.08.018 Høiby, 2010, Antibiotic resistance of bacterial biofilms, Int J Antimicrob Agents, 35, 322, 10.1016/j.ijantimicag.2009.12.011 Crabbé, 2014, Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas-aeruginosa, Pathogens and Disease, 71, 1, 10.1111/2049-632X.12180 Bjarnsholt, 2013, The <em>in vivo</em> biofilm, Trends Microbiol, 21, 466, 10.1016/j.tim.2013.06.002 Roberts, 2015, The limitations of in vitro experimentation in understanding biofilms and chronic infection, J Mol Biol, 427, 3646, 10.1016/j.jmb.2015.09.002 Schwarzer, 2020, The efficacy of topical agents used in wounds for managing chronic biofilm infections: a systematic review, J Infect, 80, 261, 10.1016/j.jinf.2019.12.017 Brackman, 2016, Dressings loaded with cyclodextrin-hamamelitannin complexes increase Staphylococcus aureus susceptibility toward antibiotics both in single as well as in mixed biofilm communities, Macromol Biosci, 16, 859, 10.1002/mabi.201500437 Spittaels, 2018, Developing an in vitro artificial sebum model to study Propionibacterium acnes biofilms, Anaerobe, 49, 21, 10.1016/j.anaerobe.2017.11.002 Vila, 2015, A new model of in vitro fungal biofilms formed on human nail fragments allows reliable testing of laser and light therapies against onychomycosis, Laser Med Sci, 30, 1031, 10.1007/s10103-014-1689-y Brandwein, 2016, Microbial biofilms and the human skin microbiome, npj Biofilms and Microbiomes, 2, 3, 10.1038/s41522-016-0004-z Burkhart, 2002, Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm, J Am Acad Dermatol, 47, 629, 10.1067/mjd.2002.124699 Gibb, 2012 Lazarus, 1994, Definitions and guidelines for assessment of wounds and evaluation of healing, Wound Repair Regen, 2, 165, 10.1046/j.1524-475X.1994.20305.x Cowan, 2010, Biofilms and their management: implications for the future of wound care, J Wound Care, 19, 117, 10.12968/jowc.2010.19.3.47281 Young, 2012, vol. 20 Thaarup, 2021, Current in vitro biofilm-infected chronic wound models for developing new treatment possibilities, Adv Wound Care, 10, 91, 10.1089/wound.2020.1176 Townsend, 2016, Development and characterisation of a novel three-dimensional inter-kingdom wound biofilm model, Biofouling, 32, 1259, 10.1080/08927014.2016.1252337 Chen, 2021, A novel chronic wound biofilm model sustaining coexistence of Pseudomonas aeruginosa and Staphylococcus aureus suitable for testing of antibiofilm effect of antimicrobial solutions and wound dressings, Wound Repair Regen, 29, 820, 10.1111/wrr.12944 Abdo, 2020, The applied anatomy of human skin: a model for regeneration, Wound Medicine, 28, 10.1016/j.wndm.2020.100179 Gilaberte, 2016, Chapter 1 - anatomy and function of the skin, 1 Löffler, 2011, Wound fluid diagnostics in diabetic foot ulcers Kadam, 2021, Milieu matters: an in vitro wound milieu to recapitulate key features of, and probe new insights into, mixed-species bacterial biofilms, Biofilms, 3 Löffler, 2013, Wound fluid in diabetic foot ulceration: more than just an undefined soup?, Int J Low Extrem Wounds, 12, 113, 10.1177/1534734613489989 Manuela, 2017, Acute and chronic wound fluid inversely influence wound healing in an in-vitro 3D wound model, J Tissue Repair Regen, 1, 1 Leyden, 2003, A review of the use of combination therapies for the treatment of acne vulgaris, J Am Acad Dermatol, 49, S200, 10.1067/S0190-9622(03)01154-X Cong, 2019, From pathogenesis of acne vulgaris to anti-acne agents, Arch Dermatol Res, 311, 337, 10.1007/s00403-019-01908-x Jahns, 2012, An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study, Br J Dermatol, 167, 50, 10.1111/j.1365-2133.2012.10897.x Dréno, 2018, Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates, J Eur Acad Dermatol Venereol, 32, 5, 10.1111/jdv.15043 Hazarika, 2021, Acne vulgaris: new evidence in pathogenesis and future modalities of treatment, J Dermatol Treat, 32, 277, 10.1080/09546634.2019.1654075 Walker, 2014, Disease manifestations and pathogenic mechanisms of group A Streptococcus, Clin Microbiol Rev, 27, 264, 10.1128/CMR.00101-13 Siemens, 2016, Biofilm in group A streptococcal necrotizing soft tissue infections, JCI Insight, 1, 10.1172/jci.insight.87882 Wu, 2021, Human organoid biofilm model for assessing antibiofilm activity of novel agents, npj Biofilms and Microbiomes, 7, 8, 10.1038/s41522-020-00182-4 Hay, 2011, Onychomycosis: a proposed revision of the clinical classification, J Am Acad Dermatol, 65, 1219, 10.1016/j.jaad.2010.09.730 Gupta, 2019, Evidence for biofilms in onychomycosis, G Ital Dermatol Venereol, 154, 50, 10.23736/S0392-0488.18.06001-7 Ghannoum, 2014, Fungal nail infections (onychomycosis): a never-ending story?, PLoS Pathog, 10, 10.1371/journal.ppat.1004105 Maciel Quatrin, 2019, Fungal infection models: current progress of ex vivo methods, Mycoses, 62, 860, 10.1111/myc.12961 Veiga, 2021, Characterization of a biofilm formed by Fusarium oxysporum on the human nails, Int J Dermatol n/a., 61, 191, 10.1111/ijd.15747 Poole, 2018, Glycointeractions in bacterial pathogenesis, Nat Rev Microbiol, 16, 440, 10.1038/s41579-018-0007-2 Salli, 2015, The use of in vitro model systems to study dental biofilms associated with caries: a short review, J Oral Microbiol, 7, 26149, 10.3402/jom.v7.26149 Yu, 2017, Dental biofilm and laboratory microbial culture models for cariology research, Dent J, 5, 21, 10.3390/dj5020021 Periasamy, 2010, Central role of the early colonizer Veillonella sp in establishing multispecies biofilm communities with initial, middle, and late colonizers of enamel, J Bacteriol, 192, 10.1128/JB.01631-09 Du, 2021, Candida albicans promotes tooth decay by inducing oral microbial dysbiosis, ISME J, 15, 894, 10.1038/s41396-020-00823-8 Zhou, 2020, Antibacterial and remineralizing nanocomposite inhibit root caries biofilms and protect root dentin hardness at the margins, J Dent, 97, 10.1016/j.jdent.2020.103344 Vila, 2020, Oral candidiasis: a disease of opportunity, J Fungi (Basel), 6, 15, 10.3390/jof6010015 de Olivera Carrilho, 2017 Wessels, 2016 Roberts, 2012, Detection of group A Streptococcus in tonsils from pediatric patients reveals high rate of asymptomatic streptococcal carriage, BMC Pediatr, 12, 10.1186/1471-2431-12-3 Lembke, 2006, Characterization of biofilm formation by clinically relevant serotypes of group A streptococci, Appl Environ Microbiol, 72, 2864, 10.1128/AEM.72.4.2864-2875.2006 Manetti, 2007, Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation, Mol Microbiol, 64, 968, 10.1111/j.1365-2958.2007.05704.x Marks, 2014, Streptococcus pyogenes biofilm growth in vitro and in vivo and its role in colonization, virulence and genetic exchange, J Infect Dis jiu, 210, 25, 10.1093/infdis/jiu058 Vyas, 2021, An optimised GAS-pharyngeal cell biofilm model, Sci Rep, 11, 8200, 10.1038/s41598-021-87377-7 Vyas, 2020, Assessing the role of pharyngeal cell surface glycans in group A Streptococcus biofilm formation, Antibiotics, 9, 775, 10.3390/antibiotics9110775 Cunningham, 2000, Pathogenesis of group A streptococcal infections, Clin Microbiol Rev, 13, 470, 10.1128/CMR.13.3.470 Gloag, 2021, Mycobacterium abscessus biofilms have viscoelastic properties which may contribute to their recalcitrance in chronic pulmonary infections, Sci Rep-Uk, 11 Chakraborty, 2021, Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis, Nat Commun, 12, 10.1038/s41467-021-21748-6 Mehta, 2010, Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries, J Cyst Fibros, 9, S5, 10.1016/j.jcf.2010.08.002 Van den Bossche, 2021, The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects, Eur Respir Rev, 30, 10.1183/16000617.0055-2021 Fung, 2010, Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum, J Med Microbiol, 59, 1089, 10.1099/jmm.0.019984-0 Iglesias, 2019, Activity of antibiotics against Staphylococcus aureus in an in vitro model of biofilms in the context of cystic fibrosis: influence of the culture medium, Antimicrob Agents Chemother, 63 Kirchner, 2012, Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung, J Vis Exp, 64 Sriramulu, 2005, Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung, J Med Microbiol, 54, 667, 10.1099/jmm.0.45969-0 Crabbé, 2017, Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum, Sci Rep, 7, 10.1038/srep43321 Bjarnsholt, 2009, 44, 547 Schierholz, 2001, Implant infections: a haven for opportunistic bacteria, J Hosp Infect, 49, 87, 10.1053/jhin.2001.1052 Nicolle, 2014, Catheter associated urinary tract infections, Antimicrob Resist Infect Control, 3, 23, 10.1186/2047-2994-3-23 Kommerein, 2018, Development and characterization of an oral multispecies biofilm implant flow chamber model, PLoS One, 13, 10.1371/journal.pone.0196967 Schmidlin, 2013, Polyspecies biofilm formation on implant surfaces with different surface characteristics, J Appl Oral Sci, 21, 48, 10.1590/1678-7757201302312 Weinstein, 2001, Device-associated infections: a macroproblem that starts with microadherence, Clin Infect Dis, 33, 1567, 10.1086/323130 Sánchez, 2014, An in vitro biofilm model associated to dental implants: structural and quantitative analysis of in vitro biofilm formation on different dental implant surfaces, Dent Mater, 30, 1161, 10.1016/j.dental.2014.07.008 Sánchez, 2011, Structure, viability and bacterial kinetics of an in vitro biofilm model using six bacteria from the subgingival microbiota, J Periodontal Res, 46, 252, 10.1111/j.1600-0765.2010.01341.x Lang, 2011, Periimplant diseases: where are we now?--Consensus of the Seventh European Workshop on Periodontology, J Clin Periodontol, 38, 178, 10.1111/j.1600-051X.2010.01674.x Quirynen, 2006, Dynamics of initial subgingival colonization of ‘pristine’peri‐implant pockets, Clin Oral Implants Res, 17, 25, 10.1111/j.1600-0501.2005.01194.x Rath, 2017, Development of a flow chamber system for the reproducible in vitro analysis of biofilm formation on implant materials, PLoS One, 12, 10.1371/journal.pone.0172095 Cornforth, 2020, Quantitative framework for model evaluation in microbiology research using Pseudomonas aeruginosa and cystic fibrosis infection as a test case, mBio, 11, 10.1128/mBio.03042-19